Used as a key intermediate in pharmaceutical synthesis, particularly in the development of kinase inhibitors for cancer treatment. Its boronic acid functional group enables Suzuki-Miyaura cross-coupling reactions, allowing efficient construction of complex biaryl structures in drug candidates. Commonly employed in medicinal chemistry for optimizing lead compounds due to its ability to enhance binding affinity and metabolic stability. Also utilized in the preparation of protease inhibitors and targeted therapies where precise molecular architecture is critical.